首頁 > 市場調查報告書 > 醫療設備

導管

神經血管器材市場規模、佔有率和成長分析（按疾病病理、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898530

神經血管器材市場規模、佔有率和成長分析（按疾病病理、最終用戶和地區分類）－2026-2033年產業預測

Neurovascular Devices Market Size, Share, and Growth Analysis, By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes), By End User (Hospitals And Surgical Centers, Ambulatory Care Centers), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，神經血管器械市場規模將達到 40.1 億美元，到 2025 年將達到 43.6 億美元，到 2033 年將達到 83.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 8.5%。

神經血管和心血管疾病發生率的上升是全球神經血管器械需求的主要促進因素。人口老化和人們對神經血管疾病認知的提高預計將進一步推動此類器械的銷售成長。微創手術的日益普及、醫療設備技術的進步以及對早期診斷的重視，預計也將成為進一步推動市場擴張的因素。此外，急性缺血性腦中風的廣泛發生也為該領域的供應商創造了新的機會。然而，高成本、監管要求嚴格以及發展中地區可及性有限等挑戰可能會阻礙市場成長。併發症和器械故障帶來的風險也可能對未來神經血管器械的需求產生不利影響。

神經血管器械市場促進因素

不健康的生活方式和選擇導致神經血管疾病的發生率不斷上升，使得越來越多的患者罹患中風和腦動脈瘤等疾病。這一令人擔憂的趨勢凸顯了有效神經血管治療設備的迫切需求，因為醫療系統正努力應對這些疾病日益沉重的負擔。因此，神經血管疾病發病率的上升催生了對先進醫療技術和設備的強勁需求，這些技術和設備旨在有效管理和治療這些疾病。推動該領域創新解決方案的舉措，體現了人們致力於改善患者預後並應對神經血管疾病挑戰的更廣泛承諾。

限制神經血管器械市場的因素

由於這些先進技術高成本，神經血管器械市場面臨巨大的限制。雖然已開發國家或許能夠負擔這些費用，但對於預算往往更為緊張的開發中國家的醫療機構而言，這卻構成了嚴峻的挑戰。這種經濟障礙會限制患者獲得必要的神經血管治療，並阻礙醫療機構在最需要這些器械的地區採用和實施這些創新設備。因此，這種限制因素會影響患者的整體治療效果以及經濟低度開發地區神經血管疾病治療的有效性。

神經血管器材市場趨勢

神經血管器械市場正呈現出顯著的微創器械發展趨勢，這主要得益於消費者對能夠更快康復、減少併發症的手術方式日益成長的偏好。這種轉變促使製造商不斷創新和改進產品，專注於開發能夠在不影響療效的前提下簡化手術流程的技術。隨著醫療機構將病患安全和舒適度置於首位，能夠輔助微創手術的神經血管器械的需求預計將會成長。該領域的持續進步和創新有望推動銷售成長，這也凸顯了製造商調整產品開發策略以適應不斷變化的市場動態的重要性。

腦動脈瘤
- 栓塞線圈
- 裸露可拆卸線圈
- 絕緣可剝離線圈
- 血流分流裝置
- 顱內支架
- 微導管
- 導管導引線
缺血性中風
- 血栓清除裝置
- 吸力/吸力裝置
- 血管勒除器
- 微導管
- 導管導引線
- 球囊導管
頸動脈狹窄
- 頸動脈支架
- 栓塞保護裝置
- 球囊導管
動靜脈畸形和瘻管
- 液態栓塞劑
- 閉塞球囊導管
- 微導管
其他疾病狀況

全球神經血管器械市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

醫院及手術中心
門診治療中心
研究和學術機構

全球神經血管器材市場規模（按地區分類）及複合年成長率（2026-2033 年）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Acandis GmbH（Germany）
Asahi Intecc Co. Ltd.（Japan）
Imperative Care Inc.（United States）
Integer Holdings Corporation（United States）
Johnson & Johnson（United States）
Medtronic plc（Ireland）
MicroPort Scientific Corporation（China）
Penumbra Inc.（United States）
Perflow Medical Ltd.（Israel）
Rapid Medical（Canada）
Stryker Corporation（United States）
Terumo Corporation（Japan）
WL Gore & Associates（United States）
Penumbra, Inc.（United States）（duplicate）
Siemens Healthineers AG（Germany）
Boston Scientific Corporation（United States）
InspireMD, Inc.（Israel）

結論與建議

簡介目錄

Product Code: SQMIG35A2777

Neurovascular Devices Market size was valued at USD 4.01 Billion in 2024 and is poised to grow from USD 4.36 Billion in 2025 to USD 8.37 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The escalating incidence of neurological and cardiovascular disorders is significantly driving the global demand for neurovascular devices. An increasing aging population and heightened awareness of neurovascular conditions are anticipated to further enhance sales of these devices. The growing preference for minimally invasive procedures, technological advancements in medical devices, and a focus on early diagnosis are additional factors expected to propel the market's expansion. Furthermore, the widespread occurrence of acute ischemic strokes presents new opportunities for suppliers in this sector. However, challenges such as high device costs, stringent regulatory requirements, and limited accessibility in developing regions may hinder market growth. The associated risks of complications and device failures could also negatively impact the future demand for neurovascular devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Devices Market Segments Analysis

Global Neurovascular Devices Market is segmented by Disease Pathology, End User and region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysms, Ischemic Strokes, Carotid Artery Stenosis, Arteriovenous Malformation & Fistulas and Other Disease Pathologies. Based on End User, the market is segmented into Hospitals And Surgical Centers, Ambulatory Care Centers and Research Laboratories and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Devices Market

The rising prevalence of neurovascular diseases, driven by unhealthy lifestyle choices and habits, has led to an increased number of individuals affected by conditions such as strokes and cerebral aneurysms. This alarming trend highlights a critical need for effective neurovascular devices, as healthcare systems strive to address the growing burden of these disorders. Consequently, the heightened incidence of neurovascular issues is creating a strong demand for advanced medical technologies and devices designed to manage and treat these conditions effectively. The push for innovative solutions in this sector reflects a broader commitment to enhancing patient outcomes and addressing the challenges posed by neurovascular diseases.

Restraints in the Neurovascular Devices Market

The Neurovascular Devices market faces a significant constraint due to the high costs associated with these advanced technologies. While such expenses may be manageable for healthcare institutions in developed nations, they pose a considerable challenge for facilities in developing countries where budgets are often tight. This financial barrier can restrict access to essential neurovascular treatments, hindering the ability of healthcare providers to adopt and implement these innovative devices in regions that would benefit from them the most. Consequently, this limitation could impact overall patient outcomes and the effectiveness of neurovascular care in less affluent areas.

Market Trends of the Neurovascular Devices Market

The Neurovascular Devices market is witnessing a significant trend towards the development of minimally invasive devices, driven by the increasing consumer preference for procedures that facilitate quicker recovery and reduced complications. This shift is prompting manufacturers to innovate and enhance their offerings, focusing on technologies that streamline surgical interventions without compromising efficacy. As healthcare providers prioritize patient safety and comfort, the demand for neurovascular devices capable of supporting minimally invasive procedures is expected to grow. Continuous advancements and innovations in this domain are likely to propel sales, underscoring the importance for manufacturers to align their product development strategies with these evolving market dynamics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Studies
Customer And Buying Criteria Analysis
Trade Analysis

Global Neurovascular Devices Market Size by Disease Pathology & CAGR (2026-2033)

Market Overview
Cerebral Aneurysms
- Embolic Coils
- Bare Detachable Coils
- Coated Detachable Coils
- Flow Diversion Devices
- Intracranial Stents
- Microcatheters
- Guidewires
Ischemic Strokes
- Clot Retriever Devices
- Suction & Aspiration Devices
- Vascular Snares
- Microcatheters
- Microguidewires
- Balloon Catheters
Carotid Artery Stenosis
- Carotid Artery Stents
- Embolic Protection Devices
- Balloon Catheters
Arteriovenous Malformation & Fistulas
- Liquid Embolic Agents
- Occlusion Balloon Catheters
- Microcatheters
Other Disease Pathologies

Global Neurovascular Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals And Surgical Centers
Ambulatory Care Centers
Research Laboratories and Academic Institutes

Global Neurovascular Devices Market Size & CAGR (2026-2033)

North America (Disease Pathology, End User)
- US
- Canada
Europe (Disease Pathology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Disease Pathology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Disease Pathology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Disease Pathology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Acandis GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imperative Care Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perflow Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rapid Medical (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WL Gore & Associates (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States) (duplicate)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments